Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 5Phase 2/3 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Lymphoma 25Leukemia 20Lymphoma, Large B-Cell, Diffuse 19Lymphoma, Non-Hodgkin 15Neoplasms 14Lymphoma, Follicular 14Recurrence 10Myelodysplastic Syndromes 10Leukemia, Myeloid, Acute 10Hematologic Neoplasms 8Burkitt Lymphoma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Neoplasms by Site 5Neoplasms by Histologic Type 5Multiple Myeloma 5Lymphoproliferative Disorders 5Lymphoma, Mantle-Cell 5Infections 5Graft vs Host Disease 5Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, T-Cell, Peripheral 3Leukemia, T-Cell 3

Interventions

remdesivir 1Standard of Care 1COVID-19 Serotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × COVID-19 × Lymphoid × Clear all
NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Klinikum Bremen-Mitte, gGmbH

Phase 2/3 Withdrawn
Lymphoid

COVID-19, Lymphoma, Follicular

NCT04873414 2021-06-02

PlaSenTer

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

Phase 2/3 Unknown
364 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡